Ketesse injection
Marketed by Ferron Par Pharmaceuticals
Ingredients in every ml
| Dexketoprofen | 25 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | N - Nervous system |
| ATC Level 2 | N02 - Analgesics |
| ATC Level 3 | N02B - Other Analgesics and Antipyretics in ATC |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
UP TO 18 YEARS
The safety and efficacy Ketesse in children have not been established and the product should not be used in children.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
18 YEARS OLD AND ABOVE
The recommended dose is 50 mg every 8-12 hours. Repeated every 6 hours if necessary. Total daily dose should not exceed 150 mg.
Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period
POSTOPERATIVE PAIN
Ketesse® can be used with opioid analgesic to overcome the pain, especially in the initial period after surgery when the pain is more painful.
Indication
Symptomatic treatment of acute pain, when oral administration is not appropriate such as postoperative pain. (IPHA p.2, Medscape p.1, PI Ketesse, Product Monograph-2 p.70, Product Profile Injection p.89, SPC p.1)